President and CEO of AltruBio Inc.
Judy Chou is the President and CEO of AltruBio Inc., a biotechnology company headquartered in the San Francisco Bay Area that is focused on developing novel antibody therapeutics for the treatment of immunological diseases with high unmet medical needs. Judy also serves on the advisory board of AIxMed, a biotech startup focusing on digital health. Before taking her role at AltruBio, Judy was a Senior Vice President and the Global Head of Biotech at Bayer Pharmaceuticals. Judy has been awarded "The Most Influential Women in Business" by San Francisco Business Times and received her PhD in Biotechnology, Cell Biology, and Neuroscience from Yale University.